What is the Share Price of Indo US Bio-Tech Ltd?

Indo US Bio-Tech Ltd share price is ₹141.10 As on 09 May, 2025|14:03

Home
>
Stocks
>
Indo US Bio-Tech Ltd

Indo US Bio-Tech Ltd Share Price

Q: What is the Market Cap of Indo US Bio-Tech Ltd?

The Market Cap of Indo US Bio-Tech Ltd is ₹312 As on 09 May, 2025|14:03

Q: What is PE Ratio of Indo US Bio-Tech Ltd?

The P/E ratio of Indo US Bio-Tech Ltd is 18.6 As on 09 May, 2025|14:03

Q: What is PB Ratio of Indo US Bio-Tech Ltd?

The PB ratio of Indo US Bio-Tech Ltd is 4.03 As on 09 May, 2025|14:03

₹ 141.10 -2.58 (-1.80%)
Updated on 09-05-2025 1:57 PM

Stock Rating

Pros 2

Cons 7

Indo US Bio-Tech Ltd Price Performance

Day's Low
₹138.13

Day's High
₹144

₹ 141.1

52-w low
₹138.13

52-w high
₹388.4

141.1

Day's open
₹143.68
Previous close
₹143.679993
VWAP
₹140.81
Lower price band
₹136.49
Upper price band
₹150.86

Today's Market Action

The last traded share price of Indo US Bio-Tech Ltd was 141.10 down by -1.80% on the NSE. Its last traded stock price on BSE was 138.60 down by -2.22%. The total volume of shares on NSE and BSE combined was 1,780 shares. Its total combined turnover was Rs 0.03 crores.

Indo US Bio-Tech Ltd Medium and Long Term Market Action

Indo US Bio-Tech Ltd hit a 52-week high of 388.4 on 10-12-2024 and a 52-week low of 138.13 on 09-05-2025. The stock price of Indo US Bio-Tech Ltd is down by -7% over the last one month. Don't forget to check the full stock price history in the table below.

Indo US Bio-Tech Ltd Fundamentals

Market Cap (Cr): 312
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Indo US Bio-Tech Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Indo US Bio-Tech Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Indo US Bio-Tech Ltd

Data not available.

Indo US Bio-Tech Ltd FAQ's

What is Share Price of Indo US Bio-Tech Ltd?

What is the Market Cap of Indo US Bio-Tech Ltd?

What is PE Ratio of Indo US Bio-Tech Ltd?

What is PB Ratio of Indo US Bio-Tech Ltd?

What is the CAGR of Indo US Bio-Tech Ltd?

How to Buy Indo US Bio-Tech Ltd Share?

Can I buy Indo US Bio-Tech Ltd from Samco?

How do I buy Indo US Bio-Tech Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
Asset Light Business
The company operates a great asset light business with a high Asset turnover ratio of 7.52. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.

Cons

Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -41.67% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 5.50 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 87.50 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 366 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(09/05/2025)

111

Margin of Safety Index: Very High

0.00%

0.00% People are bullish about Indo US Bio-Tech Ltd

100.00%

100.00 % People are bearish about Indo US Bio-Tech Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %